Article Information
PubMed
Print ISSN
Online ISSN
History
- Received January 3, 2017
- Accepted April 12, 2017
- Published online August 1, 2017.
Article Versions
- Earlier version (April 18, 2017 - 07:15).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Hao Qin,
- Yanping Ding,
- Ayeesha Mujeeb,
- Ying Zhao, and
- Guangjun Nie
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (H.Q., Y D., A.M., Y. Z., G.N.), and University of Chinese Academy of Sciences (H.Q., Y.D., Y.Z., G.N.), Beijing, China
- Address correspondence to:
Prof. Guangjun Nie, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China. E-mail: niegi{at}nanoctr.cn or Prof. Ying Zhao, University of Chinese Academy of Sciences, Beijing 100049, China. E-mail: zhaoying{at}nanoctr.cn
Statistics from Altmetric.com
Article usage
In this issue
Peptide Nanoformulations against the Tumor Microenvironment
Jump to section
- Article
- Abstract
- Introduction
- Functional Peptides
- Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations
- Ligand Peptides Mediate Nanoformulations to Target Tumor Microenvironment
- Enhanced Tumor Penetration via Tumor Microenvironment Responsive Peptides
- Peptide Self-Assembled Nanoformulations Targeting CAFs to Break Stromal Barriers
- Therapeutic Peptide Self-Assembled Nanoformulations Targeting Tumor Vasculatures
- Conclusions
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters